These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20130483)

  • 1. Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.
    Breglia MD; Carter JD
    J Clin Rheumatol; 2010 Mar; 16(2):76-8. PubMed ID: 20130483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
    Bissonnette L; April PM; Dumais R; Boire G; Roux S
    Bone; 2013 Oct; 56(2):406-9. PubMed ID: 23871749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Murray JC; Audet MC; Bédard M; Michou L
    Osteoporos Int; 2016 Feb; 27(2):833-6. PubMed ID: 26556740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-related atypical insufficiency fracture of the tibial plateau : A case report.
    Suthar A; Yukata K; Suetomi Y; Yamazaki K; Sakai T; Fujii H
    J Med Invest; 2021; 68(1.2):186-188. PubMed ID: 33994468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates.
    Skoglund K; Hjortdal O
    Tidsskr Nor Laegeforen; 2015 Jan; 135(2):116-7. PubMed ID: 25625987
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate fractures as a cause of painful total hip arthroplasty.
    Curtin BM; Fehring TK
    Orthopedics; 2011 Dec; 34(12):e939-44. PubMed ID: 22146214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetabular and sacral insufficiency fractures in a patient with a long-term history of Alendronate consumption; a case report.
    Gharanizadeh K; Ravanbod H; Aminian A; Hatami S; Chaleshtori AS; Kazerani S
    BMC Musculoskelet Disord; 2023 Mar; 24(1):211. PubMed ID: 36949509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy.
    Shaikh W; Morris D; Morris S
    J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
    Favinger JL; Hippe D; Ha AS
    Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: a cause for concern?
    Yoon RS; Hwang JS; Beebe KS
    J Bone Joint Surg Br; 2011 Oct; 93(10):1289-95. PubMed ID: 21969423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.
    Agarwal S; Agarwal S; Gupta P; Agarwal PK; Agarwal G; Bansal A
    Acta Orthop Belg; 2010 Oct; 76(5):567-71. PubMed ID: 21138208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?
    Koh JS; Goh SK; Png MA; Kwek EB; Howe TS
    J Orthop Trauma; 2010 Feb; 24(2):75-81. PubMed ID: 20101130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress fracture in long term methotrexate treatment for psoriatic arthritis.
    Wijnands M; Burgers A
    Ann Rheum Dis; 2001 Aug; 60(8):736-9. PubMed ID: 11454635
    [No Abstract]   [Full Text] [Related]  

  • 16. Femoral stress fractures associated with long-term bisphosphonate treatment.
    Ward WG; Carter CJ; Wilson SC; Emory CL
    Clin Orthop Relat Res; 2012 Mar; 470(3):759-65. PubMed ID: 22125247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
    Patel V; Graves L; Lukert B
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide.
    Tan J; Sano H; Poole K
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31340943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports.
    Tan SH; Saseendar S; Tan BH; Pawaskar A; Kumar VP
    Osteoporos Int; 2015 Feb; 26(2):421-9. PubMed ID: 25227921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical subtrochanteric fractures after long-term bisphosphonate therapy.
    Czerwiński E
    Endokrynol Pol; 2011; 62(1):84-7. PubMed ID: 21365585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.